BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,527,717 | +298.4% | 780,751 | +296.2% | 0.01% | +250.0% |
Q2 2023 | $1,387,436 | +311.3% | 197,079 | +387.3% | 0.00% | -20.0% |
Q1 2023 | $337,303 | -95.7% | 40,444 | -94.1% | 0.01% | -96.5% |
Q4 2022 | $7,826,295 | +86.7% | 681,733 | +104.8% | 0.14% | +78.8% |
Q3 2022 | $4,193,000 | +564.5% | 332,814 | +458.4% | 0.08% | +370.6% |
Q2 2022 | $631,000 | -78.7% | 59,598 | -67.4% | 0.02% | -78.5% |
Q1 2022 | $2,969,000 | +402.4% | 182,567 | +343.9% | 0.08% | +364.7% |
Q3 2021 | $591,000 | +167.4% | 41,131 | +194.7% | 0.02% | +112.5% |
Q2 2021 | $221,000 | -29.4% | 13,958 | -91.1% | 0.01% | -88.4% |
Q1 2020 | $313,000 | -12.3% | 156,507 | +51.4% | 0.07% | +200.0% |
Q4 2019 | $357,000 | – | 103,350 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |